Reservation for SC, ST is a right nobody can take away: PM

March 21, 2016

New Delhi, Mar 21: Reservation for the Scheduled Caste, Scheduled Tribes and the marginalised in the country will remain untouched, Prime Minister Narendra Modi said when he delivered the Ambedkar Memorial Lecture after he laid the foundation stone for a state-of-the-art memorial for the Dalits' rights crusader in New Delhi.

modi copyThe memorial will house Amedbakar's life’s works.

Highlights

Babasaheb was the voice of the marginalised. He is a Vishwa Manav. Only talking about him with respect to India is injustice to him: PM

The way Sardar Patel worked for Political unification, Baba Saheb Ambedkar worked for social unification: PM Modi

Few people know about the reason why Dr. Ambedkar had to resign from ministry? This part of history is either forgotten or diluted: PM

When issue of equal rights to women came up, Babasaheb was clear that if women don't get equal rights I cant be a part of the ministry: PM

Baba Saheb Ambedkar was as iconic as Martin Luther King who fought for the oppressed: PM Modi

Baba Saheb was messiah of all labourers, he was the architect of foundation labour laws: PM Modi

There is a bill oB waterways in Parliament but let me tell you this vision is of Dr. Ambedkar. He believed in India's maritime strength: PM

Baba Saheb Ambedkar was as iconic as Martin Luther King who fought for the oppressed: PM Modi

Baba Saheb was messiah of all labourers; he was the architect of foundation labour laws: PM Modi

When Vajpayee ji became PM, sections started saying reservation will go. He was PM for two terms nothing of that sort happened. Nothing has ever happened to the reservation for Dalits, tribals, where we are in power but still this lies is spread to mislead. This is a right that nobody can snatch: PM speaks on reservations for SC, ST and marginalised communities: Modi

I have got an opportunity to fulfil Baba Saheb's dream. He left us in 1956. Today, after 60 years, a memorial is being set up: PM Modi

60 years have passed! I don't know how we can explain this, but we have had to wait for 60 years for this: PM Modi

Comments

Naren kotian
 - 
Monday, 21 Mar 2016

Ummah gang chummah kodta irodu nodree . ..next time modi na defeat madtavanthe byaari galu ..haha. ..good joke ...entire 150 crore slummist sorry islamist ...united against our beloved Israel ...shyaata nu keelalikke agilla saabigalige hahaha .....innu Shri Shri sarva shakthimmaan modi na beelsakke Agatha...no ways ...anyways mouka mouka mouka ...this song I will sing here in 2019, when modiji will win next time ...jigadist infrustrure is trumbling due to tougher modi action in real estate and action of NIa ..so their dream of making India darool uloom is under threat ...so they are finding all silly reason to target sangh parivar by using kallayya kumar ...and khaali dose along with gandu ...haha...hara hara modi ...parapara jihadi ...

Clear?
 - 
Monday, 21 Mar 2016

Nobody can take away the rights of SC ST, But we will take away your right to be a PM in next election.

Abu Muhammad
 - 
Monday, 21 Mar 2016

Would your Bachelor Club @ Nagpur allow you to fulfill a fraction of what you said at Sufi Conference and Ambedkar Memorial. Next Month election (1+4 states) preparation speech???

MASTHAN
 - 
Monday, 21 Mar 2016

THEN WHY CHANT ALL ARE EQUAL.

ALL ARE NOT EQUAL. INFLUENCE AND PARTIALITY IS STILL THERE.

Musthafa
 - 
Monday, 21 Mar 2016

Feku must have copies some contents from Kanhaiya Kumar's speech. Mr. Prime minister, even if you say, it's not the right, We know that, it's their right and we will not allow you to take it away

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
August 3,2020

The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting phase 2 and 3 human clinical trials of the Oxford University developed Covid-19 vaccine candidate in the country.

Government officials said that the approval for conducting phase 2 and 3 clinical trials by the SII was granted by DCGI Dr V G Somani late Sunday night after a thorough evaluation based on the recommendations of the Subject Expert Committee (SEC) on Covid-19.

"The firm has to submit safety data, evaluated by the Data Safety Monitoring Board (DSMB), to the CDSCO before proceeding to phase 3 clinical trials," a senior official said.

"As per the study design, each subject will be administered two doses four weeks apart (first dose on day one and second dose on day 29) following which the safety and immunogenicity will be assessed at predefined intervals," the official said.

As a rapid regulatory response, the expert panel at the Central Drugs Standard Control Organisation (CDSCO) on Friday, after a detailed deliberation and considering the data generated on the vaccine candidate in phase 1 and 2 of the Oxford University trial, had recommended granting permission for phase 2 and 3 clinical trials of the potential vaccine, 'Covishield', on healthy adults in India,  the officials said.

Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa.

The officials said that the SII had submitted a revised proposal on Wednesday after the SEC on July 28, following deliberation over its application, had asked it to revise its protocol for the phase 2 and 3 clinical trials besides seeking some additional information.

The panel had also recommended that the clinical trial sites which have been proposed for the study be distributed across India.

According to the revised proposal by the SII, 1,600 people aged above 18 years will participate in the trials across 17 selected sites, including AIIMS-Delhi, B J Medical College in Pune, Rajendra Memorial Research Institute of Medical Sciences (RMRIMS) in Patna, Post Graduate Institute of Medical Education and Research in Chandigarh, AIIMS-Jodhpur, Nehru Hospital in Gorakhpur, Andhra Medical College in Visakhapatnam and JSS Academy of Higher Education and Research in Mysore.

"According to the application, it would conduct an observer-blind, randomised controlled study to determine the safety and immunogenicity of 'Covishield' on healthy Indian adults," the official said.

The SII, which has partnered with AstraZeneca, for manufacturing the Oxford vaccine candidate for Covid-19 had submitted its first application to the DCGI on July 25 seeking permission for conducting the phase 2 and 3 trials of the potential vaccine. 

Initial results of the first two-phases of trials of the vaccine conducted in five trial sites in the UK showed that it has an acceptable safety profile and homologous boosting increased antibody response, sources had said.

To introduce the vaccine, SII, the world's largest vaccine maker by number of doses produced and sold, has signed an agreement to manufacture the potential vaccine developed by the Jenner Institute (Oxford University) in collaboration with British-Swedish pharma company AstraZeneca. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
April 23,2020

More and more Indians have become better prepared in the last one month, as far as stocking of their ration, medicine or money is concerned, according to the IANS-CVoter COVID-19 Tracker.

With the second leg of the lockdown half way through and Prime Minister Narendra Modi saying it's a long haul, 57.2% respondents said they have less than three weeks of stock while 43.3% said they have a stock that will last beyond that

However, if one breaks into weeks, most respondents said they are prepared for a week's time. 24.5% respondents said they have ration, medicine or money to last a week. This is closely followed by 21.9 % respondents saying they are ready for a month.

Meanwhile, 20.4 % said they are ready for a couple of weeks. There are 15.8 % who said they are ready for more than a month with food, ration and medicine. A tiny 5.6 % said they are ready with three weeks of stock.

However, there is 12.3% who still seem to live on the edge with less than a week's preparation.

But, the biggest takeaway from the IANS-CVoter COVID-19 Tracker is that in the last one month, a massive segment of society realised that the fight is long and the preparation should also be to last that long.

o put things into context, on March 16 when the tracker started, a whopping 77.1% said they have stock to last for less than a week. More than a month later on April 21, that number jumped to just 12.3%, which essentially means, people have become better prepared for a long-hauled lockdown period.

Similarly, on April 21, a sizable 21.9% respondents claimed they are ready with ration and medicine that will last them a month. On March 16, not even one respondent could claim they have a month's stock. In fact till March 22, just ahead of the announcement of the first lockdown, no respondent the IANS-CVoter tracker said that they have a month's preparation.

Similarly, when the tracker started, 9.9% said they simply ‘don't know'. As on April 21, that number is a big zero.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 3,2020

New Delhi, April 3: The Government on Thursday launched a mobile app developed in public-private partnership as part of efforts to contain the spread of coronavirus.

"The app, called 'AarogyaSetu' will enable people to assess themselves the risk for their catching the coronavirus infection," an official release said.

It said that the app will calculate this based on their interaction with others, using cutting edge Bluetooth technology, algorithms and artificial intelligence.

"Once installed in a smartphone through an easy and user-friendly process, the app detects other devices with AarogyaSetu installed that come in the proximity of that phone. The app can then calculate the risk of infection based on sophisticated parameters," the release said.

It said that the app will help the government take necessary timely steps for assessing risk of spread of COVID-19 infection and ensuring isolation where required.

"The app's design ensures privacy. The personal data collected by the app is encrypted using state-of-the-art technology and stays secure on the phone till it is needed for facilitating medical intervention," the release said.

It said the app is available in 11 languages and has highly scalable architecture.

"This app is a unique example of the nation's young talent coming together and pooling resources and efforts to respond to a global crisis. It is at once a bridge between public and private sectors, digital technology and health services delivery," the release said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.